Physician profile
Conner Johnson
NPI 1114778065
$501.30
in general payments reported to CMS, 2019-2025
14 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $206 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $74.81 | 2024-2025 | |
| Abbvie INC. | $73.72 | 2024-2025 | |
| Novo Nordisk INC | $72.95 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $36.81 | 2025 | Airsupra |
| Lilly USA, LLC | $34.83 | 2024 | Zepbound, Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.07 | 2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $33.89 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $24.28 | 2024 | Dificid |
| Mylan Specialty L.P. | $24.22 | 2024 | Yupelri |
| Otsuka America Pharmaceutical, INC. | $23.89 | 2024 | Rexulti |
| Axsome Therapeutics, INC. | $18.71 | 2025 | Auvelity |
| Tandem Diabetes Care, INC. | $18.03 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ironshore Pharmaceuticals INC. | $17.28 | 2024 | |
| Amgen INC. | $13.81 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conner Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.